An uncontrolled long-term safety study of Diclofenac Sodium gel 1% in patients with osteoarthritis of the knee.

Trial Profile

An uncontrolled long-term safety study of Diclofenac Sodium gel 1% in patients with osteoarthritis of the knee.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 20 Apr 2012 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
    • 20 Apr 2012 Actual initiation date (Oct 2004) added as reported by ClinicalTrials.gov.
    • 24 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top